# Hike Capital

> Hike Capital is a VC fund in Beijing backing EdTech and Education. See 24 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 24
- Last investment: Apr 2026
- Lead investor: 13%
- Last updated: Aug 2026
- Website: http://www.hikecapital.com/

Hike Capital is a VC fund in Beijing focused on EdTech and Education. Formed by entrepreneurs who built their success at the cutting edge of the Internet development, Hike Capital has since its inception been sharing its own expertise in strategic management with new entrepreneurs, and helping them to gain insight in the industry trends and better define their own rhythm of growth. It is a fund that reaches furtherbeyond financing as a mentor for new entrepreneurs and accompanies them on their road to success.Founded in December 2015, the company was established by its founding partners are Mark Yang, the founder of Ganji.com and Guazi.com, and Anna Xu, NetEase’s former GM of mobile Internet and founder of NetEase News app.Some of its backed companies are Guazi.com, CHJ Automotive, Flash EX, Baby English, Huohua, and Downstairs.

## Contacts

5 contacts available for Hike Capital. Shizune tracks 6 team members at Hike Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/hike-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| EdTech | 4 | 17% |
| Education | 4 | 17% |
| Automotive | 3 | 13% |
| Biotechnology | 3 | 13% |
| EBooks | 2 | 8% |

36 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 6 | 25% |
| Series A | 5 | 21% |
| Series C | 4 | 17% |
| Series B | 3 | 13% |
| Series E | 2 | 8% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 15 | 63% |
| Indonesia | 1 | 4% |
| Singapore | 1 | 4% |
| United States | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Anna Xu | Co-Founder | 0 | https://shizune.co/investors/profile/anna-xu |
| Congwu Cheng | Venture Partner | 0 | https://shizune.co/investors/profile/congwu-cheng-abdd |
| King Zhu | Partner | 0 | https://shizune.co/investors/profile/king-zhu |
| Long Wei | Venture Partner | 0 | https://shizune.co/investors/profile/long-wei |
| Mark Yang | Co-Founder | 0 | https://shizune.co/investors/profile/mark-yang-2644 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kitar | Kitar is a professional platform for mobile phone recycling and resale, focused on making technology more sustainable and affordable by extending the lifecycle of devices through responsible collection, refurbishment, and redistribution, while also reducing electronic waste and providing consumers with access to high-quality, cost-effectivesmartphones. | $10M | Seed | Apr 01, 2026 |  |
| Qiwu Technology | Qiwu Technology is committed to empowering enterprises with smart operations in the era of big data and social networks. | $4.2M | Venture - Series Unknown | Oct 29, 2024 |  |
| Orienspace | Orienspace aims to expand development space, allow people to enjoy space civilisation, and supplement global space launch capabilities. | $84.6M | Series B | Jan 24, 2024 |  |
| Hopewell Therapeutics | Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing. It is intended to provide and services in the field of novel drug delivery systems. The technology developed by the company is based on novel synthetic lipid-based nanoparticles for nucleic acid delivery for gene therapy and gene editing. | $25M | Seed | Jun 02, 2023 |  |
| Orienspace | Orienspace aims to expand development space, allow people to enjoy space civilisation, and supplement global space launch capabilities. | $59.9M | Series A | May 20, 2022 |  |
| Artivila Therapeutics | Artivila Therapeutics is a pharmaceutical company focused on improving patient's lives through an AI-powered drug discovery engine. The company is committed to discover the best therapeutical solutions to neuro-degenerative diseases, cancers, and autoimmune diseases empowered with an integrated AI-driven innovative drug discovery platform,providing first-in-class new molecules consistently and efficiently.Artivila Therapeutics was founded in 2018 and is based in ShenZhen, China. | $15.8M | Seed | Mar 31, 2022 |  |
| Xbiome | Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to morequickly develop effective pharmaceuticals. | $100M | Series B | Dec 22, 2021 |  |
| Doublefs | e-commerce | $100M | Series A | Jun 17, 2021 |  |
| Megatronix | Megatronix is the developer of vehicle intelligent products. | $15.5M | Series C | May 17, 2021 |  |
| Yuanbao Insurance Research Institute | Yuanbao is a preferred Internet insurance platform under Yuanbao Group and has a national insurance brokerage company. | $155.9M | Series C | May 10, 2021 |  |

10 of 24 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 7 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 5 deals together
- [GSR Ventures](https://shizune.co/investors/profile/gsr-ventures-management) — VC Fund, 4 deals together
- [Luminous Ventures (former Lightspeed China Partners)](https://shizune.co/investors/profile/lightspeed-china-partners) — VC Fund, 4 deals together
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 4 deals together
- [Northern Light Venture Capital](https://shizune.co/investors/profile/northern-light-venture-capital) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Global Founders Capital](https://shizune.co/investors/profile/global-founders-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Retail Investors in China](https://shizune.co/investors/retail-investors-china)

## FAQ

### What does Hike Capital invest in?

Hike Capital invests primarily in EdTech, Education and Automotive startups, most often at Seed and Series A stage. Most of the 24 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Hike Capital?

Public channels for Hike Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Hike Capital?

The team at Hike Capital includes Anna Xu (Co-Founder), Congwu Cheng (Venture Partner) and King Zhu (Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co